Kaser DJ, Bogale B, Sarda V, Farland LV, Williams PL, Racowsky C. Randomized controlled trial of low (5%) versus ultralow (2%) oxygen for extended culture using bipronucleate and tripronucleate human preimplantation embryos.
Mischoulon D, Hylek L, Yeung AS, Clain AJ, Baer L, Cusin C, Ionescu DF, Alpert JE, Soskin DP, Fava M. Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants.
Navigated brain stimulation for upper limb recovery after stroke: Quality of life outcomes from a randomized sham controlled clinical trial of low frequency rTMS to non-injured hemisphere combined with upper limb rehabilitation.
Mischoulon D, Hylek L, Yeung AS, Clain AJ, Baer L, Cusin C, Ionescu DF, Alpert JE, Soskin DP, Fava M. Corrigendum to "Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants" [J. Affect. Disord. 208 (2017, Jan . 15 6-14, doi: 10.1016/j.jad.2016.08.029, Epub 2016 Oct. 1].
Now, this isn't a final answer to cancer, but it's a big piece of practical clinical progress, and will save lives, and it also means that it will hasten the trial of low dosage of combinations of drugs for other major tumors at major tumor sites, like colon, long, postrate, pancreas and other tumors.
It is believed to be Europe's largest real world trial of low carbon vehicles.
A phase I trial of low-dose inhaled carbon monoxide in sepsis-induced ARDS.
School gardens & physical activity: A randomized controlled trial of low-income elementary schools.
Double-blind, proof-of-concept (POC) trial of Low-Field Magnetic Stimulation (LFMS) augmentation of antidepressant therapy in treatment-resistant depression (TRD).
Döhner, H. et al. Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy.
Dr. Foster and his co-investigators in the current study, at Washington University in St . Louisand the University of Colorado Health Sciences Center in Denver, have begun a five-year trial of low-carbohydrate diets.
